Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Treatment of acute lymphoblastic leukaemia by activation of patient's immune...

Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany

Treatment of acute lymphoblastic leukaemia by activation of patient's immune cells by a bispecific antibody ( Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany )

Better understandings of gene mutations aid diagnostic tools in CLL

Dr Elías Campo - University of Barcelona, Barcelona, Spain

Better understandings of gene mutations aid diagnostic tools in CLL ( Dr Elías Campo - University of Barcelona, Barcelona, Spain )

Novel Bcl-2 specific inhibitor updated results confirm substantial activity and...

Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia

Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )

Comment: Advances in haematological cancer presented at EHA 2014

Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands

Comment: Advances in haematological cancer presented at EHA 2014 ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )

Advances in chronic lymphocytic leukaemia: Expert panel discussion

Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan

Advances in chronic lymphocytic leukaemia: Expert panel discussion ( Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan )

Genetically modified T cells fight haematological cancer

Dr Roman Galetto - Cellectis Therapeutics, Paris, France

Genetically modified T cells fight haematological cancer ( Dr Roman Galetto - Cellectis Therapeutics, Paris, France )

Investigating anticarcinogenic compounds as an alternative to chemo

Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy

Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )

HPV-targeted adoptive T Cell therapy for advanced cervical cancer

Dr Christian Hinrichs - Center for Cancer Research, Bethesda, USA

HPV-targeted adoptive T Cell therapy for advanced cervical cancer ( Dr Christian Hinrichs - Center for Cancer Research, Bethesda, USA )

PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against...

Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US

PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, US )

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma

Prof Mario Sznol - Yale Cancer Center, New Haven, USA

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma ( Prof Mario Sznol - Yale Cancer Center, New Haven, USA )

Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III...

Prof Alexander M. Eggermont, Erasmus University, Rotterdam, The Netherlands

Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III melanoma ( Prof Alexander M. Eggermont, Erasmus University, Rotterdam, The Netherlands )

HPV-targeted adoptive T Cell therapy may provide a new personalised strategy...

Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US

HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer ( Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US )

More from ecancer